AMANDA REMPE: Open Payments
NPI 1104433507 · WESTMORELAND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $51 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $66 |
| Verona Pharma, Inc. | 3 | $44 |
| Organon LLC | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Viatris Specialty LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, Ohtuvayre, NEXPLANON, LEQVIO, CRYSVITA, YUPELRI, HETLIOZ, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
